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Kaposi’s Sarcoma Herpesvirus
Genome Persistence
Franceline Juillard†, Min Tan†, Shijun Li† and Kenneth M. Kaye*
Departments of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Kaposi’s sarcoma-associated herpesvirus (KSHV) has an etiologic role in Kaposi’s
sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. These
diseases are most common in immunocompromised individuals, especially those with
AIDS. Similar to all herpesviruses, KSHV infection is lifelong. KSHV infection in tumor
cells is primarily latent, with only a small subset of cells undergoing lytic infection.
During latency, the KSHV genome persists as a multiple copy, extrachromosomal
episome in the nucleus. In order to persist in proliferating tumor cells, the viral genome
replicates once per cell cycle and then segregates to daughter cell nuclei. KSHV only
expresses several genes during latent infection. Prominent among these genes, is the
latency-associated nuclear antigen (LANA). LANA is responsible for KSHV genome
persistence and also exerts transcriptional regulatory effects. LANA mediates KSHV
DNA replication and in addition, is responsible for segregation of replicated genomes
to daughter nuclei. LANA serves as a molecular tether, bridging the viral genome to
mitotic chromosomes to ensure that KSHV DNA reaches progeny nuclei. N-terminal
LANA attaches to mitotic chromosomes by binding histones H2A/H2B at the surface
of the nucleosome. C-terminal LANA binds specific KSHV DNA sequence and also
has a role in chromosome attachment. In addition to the essential roles of N- and
C-terminal LANA in genome persistence, internal LANA sequence is also critical for
efficient episome maintenance. LANA’s role as an essential mediator of virus persistence
makes it an attractive target for inhibition in order to prevent or treat KSHV infection and
disease.
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INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV) (or human herpesvirus 8) is a large, enveloped,
double-stranded DNA virus. KSHV is the only human gamma-2 herpesvirus, belonging to the
Rhadinovirus genus. The KSHV genome is ∼165 kb, and encodes nearly 100 genes. Similar
to all herpesviruses, after infection, KSHV persists for the lifetime of its host. KSHV persists
by latently infecting cells. During latent infection, the viral genome exists as a multi copy,
extrachromosomal, circular episome (plasmid). During latent infection, only a small subset of
viral genes is expressed. These genes include the latency-associated nuclear antigen (LANA),
v-FLIP, and v-Cyclin (Chang et al., 1996; Kedes et al., 1997; Kellam et al., 1997; Rainbow et al.,
1997; Dittmer et al., 1998). Low levels of K1 transcript are also detected in latent infection,
and v-IL6 (K2) is expressed at low levels during latency in certain cell types (Chandriani and
Ganem, 2010). vIRF3 (LANA2) is expressed during latent infection, but only in B cells (Rivas
et al., 2001). The KSHV K12 locus encodes viral miRNAs which are expressed in latency
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(Samols et al., 2005), and this locus also encodes kaposins A,
B, and C, of which the kaposin B protein is the predominant
product and most easily detected during lytic infection (Sadler
et al., 1999).
LANA MEDIATES KSHV GENOME
PERSISTENCE
Latency-associated nuclear antigen is an 1162 amino acid protein
encoded by KSHV open reading frame (ORF) 73 (Figure 1) and
is the viral protein responsible for virus persistence. LANA acts
on KSHV terminal repeat (TR) sequence to mediate episome
persistence. The viral TRs are 801 bp repeated sequences that
are highly GC-rich (∼80%) and comprise ∼ 20% of the genome
(Figure 2). Upon initial infection, the linear KSHV genome
circularizes by fusing at the TR elements, located at each end of
the genome. LANA is necessary and sufficient to mediate episome
persistence of TR associated DNA in the absence of other virus
genes (Ballestas et al., 1999; Ballestas and Kaye, 2001; Garber
et al., 2001; Fejer et al., 2003; Grundhoff and Ganem, 2003, 2004;
Skalsky et al., 2007). Knockdown of LANA using siRNA leads
to loss of episomes, while deletion of LANA from a bacterial
artificial chromosome (BAC) containing the viral genome results
in loss of the ability of virus to persist in an episomal state
(Zhang et al., 2007; Li et al., 2008). Similarly, knockout or
mutating MHV-68 ORF73, the murine LANA homolog, from
murine γ-herpesvirus 68 abolishes the ability of virus to efficiently
establish latent infection (Fowler et al., 2003; Moorman et al.,
2003; Forrest et al., 2007; Paden et al., 2010; Habison et al., 2012;
Correia et al., 2013).
There are two key components to episome persistence. First,
episomal DNA must replicate with each cell division. Second,
episomes must segregate to progeny nuclei following mitosis
to avoid destruction in the cytoplasm. LANA is responsible
for both of these functions. LANA mediates episomal DNA
replication. LANA also serves to segregate KSHV episomes to
daughter nuclei. LANA accomplishes this segregation by acting
as a molecular tether for viral episomes, bridging virus DNA to
host cell mitotic chromosomes.
This review focuses on current understanding of LANA’s
mediation of genome persistence through tethering KSHV DNA
to mitotic chromosomes to effect distribution of episomes to
daughter nuclei. LANA’s role in KSHV DNA replication is
addressed separately in another chapter.
LANA Binds Chromosomes to Mediate
Viral Genome Persistence
LANA Tethers the KSHV Genome to Host Cell
Chromosomes
Using simultaneous immune fluorescence to detect LANA and
fluorescent in situ hybridization to detect KSHV DNA, LANA
was shown to colocalize with KSHV episomes along metaphase
chromosomes in KSHV latently infected cells (Ballestas et al.,
1999; Cotter and Robertson, 1999). This finding suggested LANA
had a role in KSHV episome persistence analogous to EBNA1
of Epstein-Barr virus (EBV) (Reedman and Klein, 1973; Grogan
et al., 1983; Yates et al., 1984; Harris et al., 1985), and in
fact, LANA expressing cells were shown to allow persistence
of plasmids containing KSHV TR DNA (Ballestas et al., 1999;
Ballestas and Kaye, 2001). This work led to a model in which
LANA bridges KSHV DNA to chromosomes during mitosis
through concomitantly binding to the cis-acting TRs sequence
in the KSHV genome and to mitotic chromosomes. Therefore,
LANA tethers KSHV episomes to mitotic chromosomes during
cell division to ensure segregation of the viral genome to the
nuclei of daughter cells.
N- and C-terminal LANA Independently Bind Mitotic
Chromosomes
Both N- and C-terminal regions of LANA are involved in
mitotic chromosome binding. N-terminal LANA residues 5–
22 were originally reported by Piolot et al. (2001) to target
chromatin during interphase and mitosis. N-terminal LANA
also encodes a nuclear localization signal, which is bipartite,
located within amino acids 24 to 30 and 41 to 47. Cherezova
et al. (2011) consistent with its role in tethering KSHV DNA
to mitotic chromosomes, the LANA N-terminal chromosome
association region was later shown to be essential for LANA
mediated episome persistence. Of interest, the N-terminal region
was also found to be critical for efficient LANA mediated
DNA replication, despite having no role in binding KSHV
DNA (Barbera et al., 2004; Lim et al., 2004). In addition, the
N-terminal LANA chromosome binding region also has effects
on LANA transcriptional regulation (Wong et al., 2004). Other
than microscopy, biochemical evidence also supports N- and
C-LANA interactions with chromatin (Viejo-Borbolla et al., 2003;
Wong et al., 2004).
N-terminal LANA binds directly to the surface of the
nucleosome to attach to chromosomes. X-ray crystal structure
of N-terminal LANA complexed with a nucleosome core particle
showed that the first 23 amino acids of LANA forms a hairpin
that binds exclusively to the acidic patch at the interface of
histones H2A and H2B (Barbera et al., 2006a) (Figure 3A). The
nucleosome binding property of N-terminal LANA determines
its broad distribution across mitotic chromosomes in the absence
of episomal DNA (Piolot et al., 2001; Barbera et al., 2004, 2006a;
Wong et al., 2004; Chodaparambil et al., 2007). Whether or
not histone epigenetic modifications exert a modulatory role
on N-terminal LANA binding to the nucleosome surface is not
currently known.
C-terminal LANA contains an independent chromosome
binding domain, which consists of amino acids 996–1139
(Krithivas et al., 2002; Kelley-Clarke et al., 2007a, 2009). The
LANA C-terminal domain is conserved among the LANA
orthologs from different gamma-2 herpesviruses, including
ORF73s from Retroperitoneal fibromatosis herpesvirus (RFHV)
(Burnside et al., 2006), Rhesus rhadinovirus (RRV), Herpesvirus
saimiri (HVS) (Calderwood et al., 2004), Herpesvirus ateles
(HVA), and murine gammaherpesivrus 68 (MHV68) (Grundhoff
and Ganem, 2003; Paden et al., 2012).
C-terminal LANA binds chromatin in a unique pattern in
the absence of episomal DNA, concentrating to punctate foci at
pericentromeric and peri-telomeric regions of a subset of mitotic
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FIGURE 1 | Schematic diagram of Kaposi’s sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen (LANA). Indicated are the
proline-rich region (P), and the repetitive regions (DE, QEP, QREP, QDE, L, EQE). The black areas indicate the bipartite N-terminal nuclear localization signal (NLS)
within amino acids 24 to 30 and 41 to 47. Amino acids 5 to 13 mediate chromosome association through interaction with histones H2A/H2B. Amino acids 996 to
1139 contain TR DNA binding, self-association, and chromosome association functions.
chromosomes (Krithivas et al., 2002; Kelley-Clarke et al., 2007a).
This pattern contrasts sharply with the diffuse chromosome
distribution of N-terminal LANA. Self-association of LANA
C-terminal region is required for LANA C-terminal chromosome
binding (Komatsu et al., 2004; Kelley-Clarke et al., 2009). Of other
episome maintenance proteins, EBV EBNA1 does not localize
to pericentromeric regions of sister chromatids during mitosis
(Szekely et al., 1999; Kanda et al., 2007; Nanbo et al., 2007).
The binding pattern of human papillomavirus (HPV) E2 episome
maintenance protein to chromosomes can be pericentromeric or
not, depending on the virus type (Oliveira et al., 2006).
LANA Broadly Associates with Chromatin in the
Absence of Episomes, but Concentrates to Dots on
Chromosomes at Sites of Episomal DNA
In the absence of KSHV episomes, full length LANA broadly
distributes on mitotic chromosomes (Ballestas et al., 1999;
Piolot et al., 2001). However, LANA’s distribution is uneven,
and not diffuse, when expressed at physiological levels (Kelley-
Clarke et al., 2009). Since N-terminal LANA diffusely paints
mitotic chromosomes through binding to histones H2A/H2B,
and since C-terminal LANA concentrates to pericentromeric and
peri-telomeric regions of mitotic chromosomes (as described
above), the result of combining these two localization targeting
mechanisms in full length LANA effects broad distribution over
mitotic chromosomes, but with more intense staining at peri-
telomeric and pericentromeric regions.
In stark contrast to its broad chromosomal distribution in the
absence of episomes, LANA concentrates to dots in the presence
of KSHV episomal DNA (Figure 3B), both in interphase and
along mitotic chromosomes (Ballestas et al., 1999; Cotter and
Robertson, 1999; Sakakibara et al., 2004). The concentration to
dots occurs at the sites of KSHV episomal genomes, as shown
by simultaneous immune fluorescent detection of LANA and
fluorescent in situ hybridization with KSHV DNA (Ballestas et al.,
1999; Cotter and Robertson, 1999). The strong concentration
of LANA to dots at sites of episomal DNA is likely a result
of the higher affinity that C-terminal LANA has for its DNA
binding site in TR DNA [Kd of binding to LANA adjacent
binding sites 1 and 2 ∼13.7 nM (Garber et al., 2002; Ponnusamy
et al., 2015)] compared to a lower affinity for N-terminal LANA
binding to the nucleosome [Kd ∼184 nM (Beauchemin et al.,
2014)]. Further, each KSHV genome contains ∼40 TR copies,
and each TR contains three adjacent LANA binding sites (Garber
et al., 2002; Hellert et al., 2015). Therefore, each KSHV genome
contains ∼120 LANA binding sites within its TR elements, to
which a LANA dimer binds at each site, resulting in ∼240
LANA molecules binding to TR DNA per KSHV genome. LANA
bound at TR DNA and simultaneously binding to nucleosomes
within mitotic chromosomes results in tethering of the viral
genome to mitotic chromosomes. What is less clear, however,
is whether or not a subset of LANA molecules bound at TR
DNA bind nucleosomes within the KSHV episome; such binding
would not result in tethering to mitotic chromosomes but
instead would result in LANA doubly bound to the episome:
through direct TR DNA binding and also through nucleosomal
attachment. If such binding occurs, it would potentially compete
with binding to chromosomes, and perhaps could serve as a
regulatory mechanism.
N-terminal LANA Is the Dominant Chromosome
Attachment Region
Although both N- and C-terminal LANA contain independent
chromosome binding regions, N-terminal LANA appears
to be the primary effector. Alanine substitution of key
chromosome attachment residues in N-terminal LANA abolished
LANA’s chromosome association and its ability to mediate
episome persistence (Barbera et al., 2004). In contrast, alanine
substitutions that dramatically impair C-terminal LANA’s ability
to bind mitotic chromosomes did not reduce full length LANA’s
association with chromosomes or its ability to mediate episome
persistence (Kelley-Clarke et al., 2009). It is important to note,
however, that these experiments could not use LANA that was
completely abolished for C-terminal chromosome binding.
Such null chromosome binding mutations also impaired other
critical C-terminal LANA functions, such as DNA binding.
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FIGURE 2 | Schematic representation of the circularized KSHV genome. The terminal repeats (TRs), in blue, comprise around 20% of the genome. KSHV
open reading frames (ORF) are in brown, miRNAs are in dark gray and non-coding long RNA PAN is in light gray. Alternative protein names are written in parenthesis.
Arrows indicate transcription direction. Although KSHV persistence is the focus of this article, most KSHV genes are shown. This map was generated from the
HHV-8 complete genome sequence (Genbank accession AF148805) strain GK18 using SerialCloner software.
Therefore, it remains possible that N-terminal LANA may
have “rescued” the impaired (but not abolished) C-terminal
LANA chromosome binding, possibly through a cooperative
effect. In fact, when N-terminal LANA was mutated so as
to reduce (but not abolish) N-terminal LANA chromosome
association, the C-terminal chromosome binding mutations
resulted both in a reduction of full length LANA binding
to mitotic chromosomes and also in a reduction of LANA’s
ability to mediate episome persistence (Kelley-Clarke et al.,
2009).
Altogether, these data suggest that N-terminal LANA is the
dominant effector for chromosome binding, and that C-terminal
LANA exerts an auxiliary role. It is tempting to consider that
C-terminal LANA was the original chromosome tether, and
that N-terminal LANA evolved subsequently as a more efficient
alternative. Consistent with this possibility, C-terminal LANA is
the most highly conserved region among LANA orthologs.
LANA, Including N-terminal LANA, Undergoes Post
Translational Modifications
Latency-associated nuclear antigen has been described to
undergo several types of post translational modifications. LANA
is a phosphoprotein and is the target of several host cell kinases.
Pim-1 and Pim-3 phosphorylate LANA serine residues 205
and 206 to allow lytic reactivation (Bajaj et al., 2006; Cheng
et al., 2009). RSK1 and ERK1/2 interact with LANA along
with GSK-3 and phosphorylate LANA residues located within
246–258 (Fujimuro et al., 2005; Liu et al., 2007). Notably, RSK3
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FIGURE 3 | Latency-associated nuclear antigen associates with chromosomes. (A) X-ray crystal structure of N-terminal LANA complexed with the
nucleosome. A space-filling representation is shown. (histone H2A, yellow; H2B, red; H3 light blue; H4, green; LANA, dark blue; DNA, silver). From PDB 1zla
(Barbera et al., 2006a). (B) LANA associates with cellular chromosomes in a broad distribution in the absence of episomes, and concentrates to dots on
chromosomes at sites of episomes. Cells expressing LANA were arrested in metaphase with colcemid. LANA (green) was detected with antibody directed against
LANA. DNA was counterstained with propidium iodide (red) (overlay of red and green generates yellow.) White arrows indicate LANA dots at sites of KSHV episomes.
phosphorylates LANA serine 13 and threonine 14, within the
N-terminal chromosome binding region. RSK small molecule
inhibition decreased LANA binding to histone H2B as well
as LANA protein levels. Treatment of KSHV infected PEL
cells with the RSK inhibitor resulted in growth cessation and
a decrease in viable cell numbers. In contrast, treatment of
uninfected BJAB B cell lymphoma cells resulted in growth
cessation, but there was not a decrease in the number of viable
cells. These findings show that inhibition of RSKs can impact
KSHV persistence (Woodard et al., 2012). DNA-PK was also
shown to phosphorylate LANA in at least two sites, one located
between amino acids 31–52, and a second between amino acids
91–340, although the specific residues were not identified. The
phosphorylation between residues 31–52 may have reduced
LANA mediated DNA replication (Cha et al., 2010). C-terminal
LANA is also phosphorylated at serine and threonine residues
between amino acids 951–1107, and this is mediated by a kinase
recruited by RING3 (Brd2) (Platt et al., 1999).
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In addition to phosphorylation, N-terminal LANA arginine
residue 20, located near the chromosome attachment region, was
shown to be methylated by protein arginine methyltransferase
1 and to have a role in antagonizing viral lytic reactivation
(Campbell et al., 2012). LANA is also acetylated, and sodium
butyrate (a histone deacetylase inhibitor) treatment, reduced
LANA’s ability to co immunoprecipitate with histones H2A/H2B
(Lu et al., 2006). LANA is also a target of poly (ADP-ribose)
polymerase 1 (PARP-1) and is poly (ADP-ribosyl) ated (Ohsaki
et al., 2004). The sites of acetylation or poly (ADP-ribosyl) ation
within LANA are not currently known. In addition, C-terminal
LANA is SUMOylated at lysine 1140 (Cai et al., 2013).
Cellular Proteins Associated with LANA
at the Chromosome
In addition to histones, LANA interacts with other chromosome
associated proteins. Although N-terminal LANA binding to
histones H2A/H2B is likely the primary chromosome attachment
mechanism, other cell proteins may modulate this interaction.
LANA N- and C-terminal regions both interact with the methyl
CpG binding protein 2 (MeCP2), which binds methylated CpG
dinucleotides (Krithivas et al., 2002; Matsumura et al., 2010).
MeCP2 was initially proposed to mediate N-terminal LANA
chromosome association based on the inability of LANA to
associate with murine chromosomes in the absence of human
MeCP2, although other work demonstrated LANA associates
with native murine chromosomes (Krithivas et al., 2002; Barbera
et al., 2006b; Kelley-Clarke et al., 2007a). The interaction
between LANA and MeCP2 may confer LANA with the potential
to regulate cellular gene expression in latently infected cells
(Matsumura et al., 2010). Of note, MeCP2 was shown to be
important for herpesvirus saimiri LANA episome persistence
(Griffiths and Whitehouse, 2007). LANA also interacts with
the DEK protein, which associates with chromatin. The DEK-
interacting region was mapped to LANA amino acids 986 to
1043 and DEK was proposed to mediate C-terminal LANA
attachment to chromosomes (Krithivas et al., 2002), although
unlike C-terminal LANA’s concentration to pericentromeres
and peri-telomeres, DEK diffusely paints mitotic chromosomes
(Krithivas et al., 2002; Kelley-Clarke et al., 2007a). Full length
LANA was shown to interact with histone H1 (Cotter and
Robertson, 1999), and a chimeric LANA with the N-terminal
chromosome association region replaced by histone H1 protein
was functional for episomal maintenance (Shinohara et al.,
2002). Results differ as to whether histone H1 can interact
with N-terminal LANA (Barbera et al., 2006a; Verma et al.,
2013).
KSHV LANA also interacts with BET (Bromodomain and
Extra Terminal domain) proteins (Platt et al., 1999; Ottinger et al.,
2006). The BET protein BRD4 binding sites on LANA have been
mapped to LANA amino acids 475 to 777 and C-terminal amino
acids 982 to 1162 (Viejo-Borbolla et al., 2005; You et al., 2006).
BET proteins such as BRD2 and BRD4 have two bromodomains
and an extraterminal (ET) domain. BET proteins interact with
C-terminal LANA through the BET protein ET domain and
also through a conserved serine rich region downstream of the
ET domain (Hellert et al., 2013). BET protein bromodomains
bind acetylated tails of histones H3 and H4 and may have a
role in LANA’s transcriptional properties (Viejo-Borbolla et al.,
2005; Ottinger et al., 2006; You et al., 2006). Notably, bovine
papillomavirus E2, which is an episomal maintenance protein,
attaches to chromosomes through the bromodomain of BRD4
(You et al., 2004).
Nuclear Mitotic Apparatus (NuMA), a protein interacting
with microtubule dynein/dynactin during mitosis, binds
C-terminal LANA and associates with LANA during interphase
and at the end of telophase. Repressing NuMA function led to a
reduction in episomal maintenance (Si et al., 2008). LANA also
associates with the kinetochore proteins CENPF and BUB1. Both
N- and C-terminal LANA are involved in CENPF and BUB1
association and the interaction between CENPF and LANA leads
to colocalization of LANA with these kinetochore proteins in a
subset of ∼50% of mitotic chromosomes in KSHV infected PEL
cells (Xiao et al., 2010). Bub1, but not CENPF depletion with
RNA interference led to a reduction in KSHV episome copy
number in PEL cells (Xiao et al., 2010). LANA also targets BUB1
for degradation which can lead to chromosomal instability (Sun
Z. et al., 2014). PARP-1 binds KSHV TR DNA. PARP-1 activity
may control viral copy number in infected cells. Treatment
of BC3 PEL cells with hydroxyurea, a compound that elevates
PARP activity, decreased KSHV copy number and treatment
with niacinamide and 3-aminobenzamide, which decrease PARP
activity, increased KSHV copy numbers (Ohsaki et al., 2004).
The DNA-PK/Ku complex associates with N-terminal LANA,
and phosphorylates LANA. Overexpression of the catalytic
subunit Ku70, but not Ku86, impaired LANA replication of a TR-
containing plasmid in 293T cells. This suggests that DNA-PK/Ku
may negatively regulate KSHV latent replication (Cha et al.,
2010). LANA localizes to heterochromatin and interacts with
heterochromatin protein 1 (HP1), which is a chromodomain
containing protein, and SUV39H1, a histone methyltransferase,
at chromosomes (Szekely et al., 1999; Lim et al., 2003; Sakakibara
et al., 2004). Histone H2AX also interacts with LANA and
its phosphorylated form, gamma H2AX colocalized with a
subset of LANA dots. Knockdown of H2AX decreased KSHV
episome copy number (Jha et al., 2013). HMGA1 or HMGB1
also interact with LANA and chromosomes (Shamay et al.,
2012).
LANA Binds Viral TR DNA through Its
C-terminal Domain to Mediate Viral
Genome Persistence
LANA Binds Specific Sequence in the KSHV TR
Element
Latency-associated nuclear antigen binds TR DNA to mediate
KSHV DNA replication and to tether episomes to mitotic
chromosomes. The finding that LANA acted on KSHV TR
associated DNA to mediate episome persistence in the absence of
other virus genes led to the hypothesis that LANA can directly
interact with TR DNA. Subsequently, a 20 bp sequence in the
TR was identified as a LANA binding site (LBS1) and was
bound by the LANA C-terminal domain, also referred to as the
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DNA binding domain (DBD) (Ballestas and Kaye, 2001; Cotter
et al., 2001; Garber et al., 2001). Mutagenesis of the LANA
binding site revealed that the 6CCC8 nucleotides of LBS1 are
critical for LANA interaction. Substitutions of these nucleotides
severely impacted LANA binding. In contrast, mutations within
other nucleotides had only modest effects on binding (Srinivasan
et al., 2004). A second LBS (LBS2) was identified downstream
of LBS1 through electrophoretic mobility shift assay (EMSA)
and DNase I footprinting experiments (Garber et al., 2002).
Compared to LBS1, LBS2 is a low affinity LANA binding site.
However, since LBS2 is adjacent to LBS1, LBS1 is capable of
facilitating cooperative binding of LANA to LBS2 (Garber et al.,
2002). Recently, a third LBS (LBS3) was identified, also adjacent
to LBS1, but with inverse orientation compared to LBS1 and LBS2
(Hellert et al., 2015) (Figure 4A). Similar to LBS2, LBS3 is a low
affinity binding site with about a 100-fold lower LANA binding
affinity compared to LBS1. Interestingly, LANA DBD binding to
LBS1 and LBS3, or to LBS2–LBS1–LBS3 proceeds in a biphasic
manner, with LANA binding to LBS1 (or cooperatively to LBS2–
LBS1) in the first phase, and then binding LBS3 in the second
phase (Ponnusamy et al., 2015). The biphasic binding to LBS3
could be due to the slightly greater distance between LBS1 and
LBS3 as compared to LBS1 and LBS2 (Ponnusamy et al., 2015).
LBS3 was previously recognized as a 32 bp sequence essential for
LANA mediated replication of TR DNA, and had been termed
the replication element (Hu and Renne, 2005). Although all
three LBSs share homologous sequence, both LBS2 and LBS3
harbor a cytosine to guanine transversion at position 8 (Hellert
et al., 2015). Considering the critical role of this cytosine for
LBS1 binding affinity (Srinivasan et al., 2004), it is very likely
that the low binding affinities for LANA of LBS2 and LBS3
arises from this cytosine to guanine substitution at position 8.
The spacing of 22 bp between each LBS results in location of
the LBS’s on the same face of DNA, thereby allowing adjacent
LANA dimers to bind cooperatively (Garber et al., 2002; Hu
and Renne, 2005; Hellert et al., 2015). In addition to binding
viral DNA, LANA is capable of binding host genomic DNA.
Chip-seq data shows that host LANA-binding sites are generally
found within transcriptionally active promoters with sequence
homology to the characterized LBS’s within TR DNA (Lu et al.,
2012; Hu et al., 2014; Mercier et al., 2014). A novel LANA
binding motif (TCCAT)3, which is only present in host LANA-
binding sites, and to which LANA binds with low affinity, similar
to LBS2, was also confirmed by gel shift analysis (Hu et al.,
2014).
Mutagenesis has also defined residues within the LANA
DBD as important for DNA binding (Figure 4B). LANA
mutants which are deficient for, or lack DNA binding ability,
are also deficient or abolished for the ability to mediate
KSHV DNA replication or episome persistence (Komatsu et al.,
2004; Han et al., 2010). The inability of LANA abolished for
DNA binding to mediate episome persistence is due both
to an inability to replicate KSHV DNA as well as loss of
the ability to tether KSHV episomes to mitotic chromosomes
to segregate episomes to daughter nuclei. C-terminal LANA
also mediates LANA’s self-association, and self-association is
necessary for DNA binding; deletions in C-terminal LANA
that result in the loss of LANA self-association also result in
loss of DNA binding and episome persistence (Schwam et al.,
2000; Komatsu et al., 2004). As noted above, C-terminal LANA
concentrates to percicentromeres and peri-telomeres of a subset
of mitotic chromosomes in addition to binding KSHV TR DNA.
Alanine scanning mutagenesis of C-terminal LANA revealed that
different subsets of residues are important for binding to TR
DNA versus mitotic chromosomes (Kelley-Clarke et al., 2007b;
Han et al., 2010). Therefore, C-terminal LANA does not appear
to attach to mitotic chromosomes through recognition of its TR
DNA binding sequence.
Structure of the LANA DNA Binding Domain
The x-ray crystal structures of the KSHV and MHV68 LANA
DNA binding domains were recently solved (Correia et al., 2013;
Domsic et al., 2013; Hellert et al., 2013, 2015; Ponnusamy et al.,
2015). These revealed an alpha-beta fold that assembles as a
dimer, and that is structurally similar to the EBV EBNA1 and
papillomavirus E2 DBDs. The hydrophobic interface of LANA
DBD dimerization interface is mediated by an eight-strand
anti-parallel intermolecular β-barrel to which each monomer
contributes four β-sheets (Domsic et al., 2013; Hellert et al.,
2013, 2015). However, in contrast to EBNA1 and E2, a unique
feature of LANA is a positive electrostatic patch on the surface
opposite of the DNA binding surface. This positive patch serves
to interact with BET proteins, although BET proteins also
interact with a second region (residues 1125–1129) in C-terminal
LANA (Hellert et al., 2013). Mutation of the positive patch
reduced LANA’s ability to mediate DNA replication and episome
persistence, and mutation of the peripheral region of the positive
patch generated the most severe effects, compared to mutation
of other portions of the patch (Correia et al., 2013; Domsic
et al., 2013; Hellert et al., 2013; Li et al., 2015). These deficiencies
in replication and maintenance were unrelated to BET protein
binding (Correia et al., 2013; Li et al., 2015). Mutation of the
analogous positive patch in MHV68 LANA impacted the ability
of MHV68 to establish latent infection in mice (Correia et al.,
2013; Hellert et al., 2013).
Another notable finding of the LANA structure was an
oligomerization interface between LANA dimers. This ability of
adjacent LANA dimers to interact underlies LANA’s cooperative
binding to adjacent DNA binding sites. Disruption of this
interface results in loss of LANA cooperative binding to LANA
binding sites such as LBS1 and LBS2, deficient DNA replication,
and deficient episome persistence (Domsic et al., 2013; Hellert
et al., 2013). Importantly, the hydrophobic interface that mediates
the dimer–dimer interaction results in a bend and also is a
flexible pivot point that allows rotation and bending between two
adjacent dimers (Ponnusamy et al., 2015). Variation in the degree
of bend between adjacent dimers can result in LANA DBD dimers
oligomerizing to form ring structures consisting of different
numbers of dimers (e.g., four or five dimers) (Figure 5A). In
these LANA structures, the DNA binding surface of each dimer
is on the exterior face (Domsic et al., 2013; Hellert et al.,
2013, 2015). In addition, LANA dimers can form non-ring
structures (Figure 5B) as well as a spiral (Hellert et al., 2015;
Ponnusamy et al., 2015). MHV68 LANA also forms oligomers
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FIGURE 4 | Latency-associated nuclear antigen binds specific sequence in KSHV TR DNA. (A) TR sequence with LBS sequences indicated by arrows and
highlighting. (B) C-terminal LANA residues. Residues which impact DNA binding by EMSA (Kelley-Clarke et al., 2007b; Han et al., 2010) are highlighted in blue and
those involved in oligomerization (Correia et al., 2013; Domsic et al., 2013; Hellert et al., 2013, 2015; Ponnusamy et al., 2015) of LANA dimers are highlighted in
orange. (C) Crystal structure of C-terminal LANA complexed with LBS1 (Hellert et al., 2015) PDB:4UZB. One LANA monomer is shown in blue, and the other in
green.
through interactions between adjacent dimers, which mediates
cooperative binding to adjacent binding sites in MHV68 TR
DNA. However, in contrast to KSHV LANA, MHV68 LANA
forms a rigid, linear conformation compared to KSHV LANA’s
bent, flexible configuration (Hellert et al., 2013; Ponnusamy et al.,
2015).
LANA Recognition of DNA
A recent x-ray crystal structure of the KSHV LANA DBD
bound to the high affinity LBS1 recognition site was solved,
revealing insight into LANA’s recognition of DNA (Hellert et al.,
2015) (Figure 4C). To obtain the structure, point mutations
were introduced in the DBD in order to obtain well-behaved
complexes with DNA. Notably, and in contrast to EBNA1 or
E2’s recognition of DNA (Hegde et al., 1992; Bochkarev et al.,
1996), the LANA DNA dimer binds LBS1 with remarkable
asymmetry, with the primary sequence recognition occurring
within G5 to G10 of the 20 bp LBS1. These findings are consistent
with mutagenesis studies of LBS1 as discussed above, which
revealed that alteration of LBS1 6CCC8 nucleotides resulted
in severe deficiency of LANA binding as compared to other
mutations (Srinivasan et al., 2004). The N-terminal arm residues
of one monomer, and helices 1 and 2 of the second monomer
make sequence specific contacts with base pairs G5 to G10.
The corresponding residues of the other monomer within the
dimer make contact only with the DNA backbone. Deletion
(LANA11007–1021) or point mutations (R1013, Y1014) within
the N-terminal arm of the LANA DBD ablates TR DNA binding,
replication and episome maintenance (Komatsu et al., 2004;
Domsic et al., 2013). A bend of 25◦ is introduced in DNA by
the bound LBS1 DNA, which is less than the previously reported
bend of 57◦, but could be due to crystal packing constraints
(Wong and Wilson, 2005).
In addition to sequence specific binding, the LANA DBD was
also proposed to bind DNA in a sequence independent manner
(Hellert et al., 2015). In both the ring forms (Figure 5A) and
spiral structures (as described above) formed by oligomerizing
LANA dimers, the sequence specific binding surface is located on
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FIGURE 5 | Higher-order crystal structures of the KSHV LANA DNA
binding domain. (A) Ring form structure of the KSHV LANA DNA binding
domain composed of 5 dimers (from PDB:4K2J.) (Domsic et al., 2013). (B)
Non-ring form tetramer structure of KSHV LANA DNA binding domain (from
PDB:5A76.) (Ponnusamy et al., 2015).
the outside of the rings or spiral, and the positive electrostatic
patch is located on the inside of the rings or circle, to form a
continuous, positively charged inner surface. The inner diameter
of the rings or spiral is large enough to accommodate double
stranded DNA. In fact, negative staining electron microscopy
demonstrated that LANA DBDs mutated for sequence specific
binding, were able to form complexes on an arbitrary dsDNA
fragment. Mutations of the oligomerization surface or of the
positive electrostatic patch abolished the LANA DBD’s ability
to complex with the DNA fragment (Hellert et al., 2015). It
is possible that related, higher order structures of LANA may
account for the LANA dots observed when LANA concentrates
at episomes in cells.
Role of Internal LANA Sequences in Viral
Persistence
Although both the N-terminal LANA chromosome attachment
region and the C-terminal DBD are essential for episome
maintenance, they are insufficient for efficient KSHV episome
persistence. Accordingly, fusion of N-terminal (aa 1–32) and
C-terminal (aa 929–1162) LANA is highly deficient for episome
maintenance, despite its ability to bind mitotic chromosomes
and TR DNA at WT levels (De Leon Vazquez and Kaye,
2011). The internal LANA sequence can be divided into
two major components: unique sequence, located between
amino acids 33 and 331, which includes a proline-rich
region from amino acids 63 to 271, and large region of
imperfect repeat elements between residues 332 and 931
(Figure 1). Both these regions contribute to viral episome
maintenance.
The unique internal sequence exerts an important role
for episome maintenance. LANA133–273, which contains a
deletion of amino acids 33 to 273, was highly impaired for
episome maintenance of a plasmid containing eight TR elements.
LANA133–273 was also deficient for the ability to replicate
TR DNA in transient assays. A number of different host cell
proteins involved in DNA replication have been described to
interact physically or functionally with LANA including origin
recognition complex (ORC) proteins 1-6, mini-chromosome
maintenance complex (MCM), HBO1, a histone acetyltransferase
important for DNA replication licensing, topoisomerase IIbeta
(TopoIIbeta), ubiquitin specific protease USP7, structure-specific
recognition protein 1 (SSRP1), replication proteins A1 and A2,
replication factor C (RFC), and the proliferating cell nuclear
antigen (PCNA) (Lim et al., 2002; Stedman et al., 2004; Verma
et al., 2006; Jager et al., 2012; Purushothaman et al., 2012;
Shamay et al., 2012; Sun Q. et al., 2014, Sun et al., 2015).
However, none of these proteins have yet been mapped to this
region of LANA, although deletion of residues 262–320, which
partially overlaps residues 33–273, abolished RFC interaction.
It is possible that one of these, or other host cell proteins
may interact with this region to exert effects on LANA’s DNA
replication.
In addition to replication deficiency, the unique internal
sequence 33–331 was found to be important for segregation of
TR DNA to progeny nuclei. Segregation ability was assessed
with a GFP reporter plasmid containing two TR elements
that are incompetent for LANA mediated DNA replication
due to deletion of LBS3 (formerly termed the replication
element) (Hu and Renne, 2005; Skalsky et al., 2007). LANA
still maintains the ability to bind this plasmid since LBS1
and LBS2 remain present. Despite preservation of DNA
binding and chromosome binding, which allow tethering of
TR DNA to mitotic chromosomes, LANA deleted for residues
within 33–331 was deficient for the ability to segregate
DNA to daughter nuclei (as assessed by retention of GFP
expression), while deletion mutants containing residues 33–
331 were WT for segregation (De Leon Vazquez et al., 2013).
It is possible that this sequence may interact with a host
cell protein important for a process such as ensuring that
histones bound with LANA are deposited onto newly formed
nucleosomes during DNA replication. Alternatively, this region
could be responsible for ensuring that LANA molecules with
bound episomes are distributed onto sister chromatids. It
is possible that facilitating chromatin transcription (FACT),
which disrupts and reassembles nucleosomes through removal
and deposition of histones H2A/H2B, could have such a
role since LANA interacts with the FACT component, SSRP1
(Reinberg and Sims, 2006; Tan et al., 2006; Hu et al., 2009).
It is also possible that HMGA1 or HMGB1, which interact
with LANA and remodel chromatin (Shamay et al., 2012),
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FIGURE 6 | Schematic representation of episome persistence through the cell cycle. LANA tethers the episome to the cellular chromosome. During S
phase, the viral episome replicates once in concert with cell DNA (Verma et al., 2007). A potential model is shown of two replicated episomes attaching to adjacent
sister chromatids and segregating to daughter nuclei through tethering to chromatids.
could have a role in LANA segregation. The interactions
of HMGA1, HMGB1, and SSRP1 within LANA have not
been mapped. The LANA interacting kinetochore proteins,
CENPF or Bub1, are other intriguing possibilities, and these
interact with LANA 1–340 and amino acids 842–1162, which
therefore includes the unique internal region (Xiao et al.,
2010).
Latency-associated nuclear antigen also has several motifs
within the unique internal sequence that could have roles in
replication or segregation. A bipartite LANA SUMO-interacting
motif (SIM), which interacts with SUMO-2 modified proteins,
such as the transcription factor KAP1, is located at residues 244–
250 and 264–270, and has been shown to be important for LANA
mediated episome persistence (Campbell and Izumiya, 2012;
Cai et al., 2013). LANA contains at least one phosphorylation
site within amino acids 31–52, and is also phosphorylated at
additional sites within 91–340 as discussed above (Fujimuro et al.,
2005; Liu et al., 2007; Cha et al., 2010). In addition, there is a
suppressors of cytokine signaling (SOCS) box-like motif which
contains an Elongin B and C box located at LANA residues 212–
222. LANA also has another component of the SOCS box motif,
a Cullin box, which is spatially separated from the elongin B/C
motif, and is located at residues 1085–1100 within the C-terminal
domain (Cai et al., 2006). It is possible that any of these sites
within the unique internal sequence may contribute to LANA
mediated segregation or replication.
The LANA internal repeat region consists of glutamine rich
and acidic imperfect repeat elements spanning from amino
acids 332–931 (Russo et al., 1996). The length of each region
and the number of repeats varies depending on the virus
isolate (Rainbow et al., 1997). Deletion of the entire repeat
region between residues 332 to 929 diminishes LANA’s ability
to mediate episome persistence of a small plasmid containing
eight TRs to a modest degree compared to deletion of most
of the unique internal sequence (residues 33–273) (∼10-fold
vs. ∼275-fold, respectively) (De Leon Vazquez et al., 2013).
However, deletion of the repeat elements had a potent effect
on persistence of the entire KSHV genome. A BAC containing
the KSHV genome with LANA deleted for amino acids 329–
931 lost the ability to persist. After transfection of cells with
this BAC, no colonies formed under drug selection. This loss
was not due to a major replication defect, as the LANA
mutant retained the ability to replicate a plasmid containing
TR DNA in a transient assay (Alkharsah and Schulz, 2012).
Therefore, both the unique internal sequence and the internal
repeat elements contribute to LANA episome persistence
function.
KSHV Episome Persistence Is a Multi
Step Process and May Require
Epigenetic Changes for Longterm
Stability
As discussed above, there are two steps necessary for viral
episome maintenance in proliferating cells (Figure 6). First, the
viral episomes replicate in concert with cell DNA once per cell
cycle using a semiconservative mode of replication (Verma et al.,
2007). Second, replicated episomes must be efficiently dispatched
to daughter cells. This critical process involves tethering the viral
genomes to cellular mitotic chromosomes to allow migration
of episomes to the nuclei of daughter cells, thereby avoiding
viral DNA degradation in the cytoplasm. Although the terms
“segregation” or “partitioning” are sometimes used to describe
different components of this process, such terms tend to be
arbitrary as the process is a continuous one that accomplishes the
global goal of ensuring that replicated episomes are distributed to
daughter nuclei.
The attachment of LANA bound KSHV episomes to
nucleosomes is likely a multi-step process. For instance, histones
are removed from DNA prior to its replication and re-deposited
following replication. It is possible that LANA may remain
bound to histones throughout this process or that LANA may
be removed from histones, and then reattached to nucleosomes
following DNA replication. Further, if LANA deposition on sister
chromatids is not random, a mechanism must exist to ensure
equal episome distribution to each sister chromatid.
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FIGURE 7 | Model of LANA tethering the KSHV genome to a
chromosome. N-terminal LANA (N) binds to core histones H2A/H2B.
C-terminal LANA (C) self-associates, binds to KSHV TR DNA in the KSHV
genome, and binds to a putative protein (X) that associates with the
chromosome.
A faithful segregation system of newly replicated episomes
to daughter cells would seemingly be the most efficient method
of distribution. Notably, it has been observed that a similar
KSHV genome copy number appears to be maintained in infected
cells within a population (Ueda et al., 2006), consistent with a
faithful partitioning mechanism. In addition, equivalent amounts
of chromosome associated GFP LANA appeared to partition in
dividing, uninfected cells, also suggesting faithful partitioning
(Tetsuka et al., 2004). However, work using a KSHV BAC marked
with tandem lactose operator sequences to allow binding of a
lactose repressor protein fused to fluorescent protein suggested
KSHV may partition randomly (Norby et al., 2012). For EBV,
episome segregation has been shown to be a non-random process
(Nanbo et al., 2007).
Despite the persistence of stable copy numbers of KSHV
episomes in infected cell lines, such as primary effusion
lymphoma (PEL) cells, the establishment of stable KSHV
persistence is a relatively inefficient process in vitro (Grundhoff
and Ganem, 2004; Ueda et al., 2006). In fact, the use of a
selection marker is necessary for efficient selection of cells with
persistent maintenance of episomes (Tetsuka et al., 2004; Ueda
et al., 2006). This situation is similar to that of EBV, where the
establishment of stable EBNA1 mediated episome persistence of
oriP plasmids is also inefficient (Leight and Sugden, 2001). It
is likely that cis acting, epigenetic changes in the viral episome
are necessary for stable persistence, and that such changes
occur at a relatively low frequency. However, once they have
occurred, episome maintenance remains stable (Grundhoff and
Ganem, 2004; Skalsky et al., 2007). It has been hypothesized
that lytic infection may be important for KS tumorigenesis
due to the inefficiency of KSHV persistence following infection.
Lytic infection could potentially recruit new infected cells
to replace those that lose KSHV infection (Grundhoff and
Ganem, 2004). However, an alternative explanation is that the
local microenvironment in vivo may provide critical conditions
that are necessary for efficient persistence of KSHV following
infection.
CONCLUSION
Kaposi’s sarcoma-associated herpesvirus genome persistence is
mediated by the viral LANA protein. LANA mediates viral
DNA replication and tethers KSHV DNA (Figure 7) to mitotic
chromosomes to segregate episomes to progeny nuclei (Figure 6).
To tether episomes to chromosomes, N-terminal LANA directly
interacts with the folded portion of the nucleosome at the
conserved acidic patch at the interface of histones H2A and
H2B. C-terminal LANA also interacts with chromosomes, likely
by binding a chromosomal protein. In addition, C-terminal
LANA mediates the interaction with viral DNA by binding
sequence within the TR elements. The structure of the
LANA DBD was recently solved and suggests that cooperative
binding of LANA to its adjacent binding sites within each
TR is mediated by interactions between LANA dimers. LANA
dimers can assemble into higher-order structures, mediated
by dimer-dimer interactions. LANA interacts with a number
of cellular proteins, including at the chromosome. Through
these interactions, LANA exerts its functions, including KSHV
DNA replication and segregation. Although N and C-terminal
LANA are necessary, they are not sufficient for efficient episome
maintenance. LANA internal regions also exert important roles
necessary for maintenance of episomes. The essential role
of LANA in episome persistence makes it an ideal target
for inhibition for the treatment and prevention of KSHV
malignancies. Inhibition of any critical component of LANA’s
episome persistence function, including binding to TR DNA
or to mitotic chromosomes, is expected to abolish KSHV
persistence, and eliminate virus infection from proliferating
cells.
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